Tuberculosis Laboratory Testing Services for U. S. Pacific Islands

Closed Solicitation Posted

Solicitation number
75D301-20-R-67962
Agency
CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Place of performance
Atlanta GA 30329 USA

Notice details come from SAM.gov. Updated .

About this opportunity

This solicitation seeks tuberculosis laboratory testing services for ten US Pacific Islands locations. The Centers for Disease Control and Prevention requires specimen transport, laboratory testing including smear microscopy, culture, identification and drug susceptibility testing for up to 4,500 specimens annually. Optional travel services for site visits and conferences are also solicited. Responses are due by July 30, 2020 and will be evaluated on past performance, technical approach, and price. The base period of performance is one year with four one-year option periods, for a total potential contract value of five years.

There is no set-aside designation. The primary NAICS code is 541715 and PSC code is D399. Laboratory testing will be performed at the contractor's site with a place of performance in Atlanta, GA. Pricing will be firm-fixed-price for laboratory services and cost-reimbursement for travel. The total estimated budget is $2 million annually including all option periods.

Notice text

This requirement is for Tuberculosis laboratory testing services for the ten US-Pacific Islands.

The period of performance for this requirement will include a base period of one-year (12 months), followed by four one-year (12 month) option periods.

Please see the attached solicitation for more detailed information.

Attachments

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity